search
Back to results

Anodyne Therapy in Diabetic Sensory Neuropathy

Primary Purpose

Diabetes Mellitus, Diabetic Neuropathy

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Anodyne Therapy System
Sponsored by
Scott and White Hospital & Clinic
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus

Eligibility Criteria

25 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Subjects with diabetes mellitus and peripheral sensory neuropathy. Subjects at least 25 years old. Vibration perception threshold (VPT) ≥ 20 volts and ≤ 45 volts. Subjects must be alert, oriented, mentally competent and able to understand and comply with the requirements of the study, and provide voluntary informed consent. Subjects must be willing and able to complete the required study visits and record treatment activity in the study logbook. Exclusion Criteria: Subjects who have a VPT <20 or > 45 volts. Subjects with uncontrolled hypertension greater than 180 systolic or greater than 110 diastolic as determined by enrollment questionnaire Subjects who are pregnant or breastfeeding or who are likely to become pregnant during the course of the study. Subjects with active malignancy (including basal cell carcinoma) on the lower extremities. Subjects who have had prior reconstructive or replacement knee surgery with neurological deficits related to the surgery. ( If the patient has had knee surgery, their neuropathy appears to be uniform and bilateral, then they can be included in the study). Subjects with a history of previous back surgery, spinal stenosis, or spinal compression or radiculopathy with neurological deficits related to spinal cord pathology. ( If the patient has had back surgery, their neuropathy appears to be uniform and bilateral, then they can be included in the study). Subjects who are non-ambulatory. Subjects with a history of neuromuscular disease, leprosy, chronic alcoholism, or sarcoidosis. Subjects with foot ulcerations. Subjects with a transmetatarsal amputation or higher

Sites / Locations

  • Scott and White Santa Fe Center

Outcomes

Primary Outcome Measures

changes in sensation using, vibration perception threshold testing, monofilament testing, and the Michigan Neuropathy Screening Instrument

Secondary Outcome Measures

Full Information

First Posted
June 30, 2005
Last Updated
May 30, 2007
Sponsor
Scott and White Hospital & Clinic
Collaborators
Anodyne Therapy, LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT00120341
Brief Title
Anodyne Therapy in Diabetic Sensory Neuropathy
Official Title
A Randomized, Double Blind, Placebo Controlled Prospective Study to Evaluate the Effectiveness of Monochromatic Infrared Photo Energy to Improve Diabetic Sensory Neuropathy
Study Type
Interventional

2. Study Status

Record Verification Date
May 2007
Overall Recruitment Status
Completed
Study Start Date
April 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
June 2006 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Scott and White Hospital & Clinic
Collaborators
Anodyne Therapy, LLC

4. Oversight

5. Study Description

Brief Summary
The purpose of this research study is to determine if the use of a series of the Anodyne Therapy System in-home treatments over a 90-day period will improve peripheral sensation and quality of life in persons with diabetes mellitus.
Detailed Description
The morbidity, direct cost and mortality associated with lower extremity complications among patients with diabetes mellitus have been well described in the medical literature. Peripheral sensory neuropathy is one of the strongest risk factors for both foot ulceration and amputation in this population. In the absence of neuropathy people rarely develop foot ulcers. Because of the lack of painful feedback, peripheral neuropathy provides a permissive environment that allows repetitive tissue injury to occur such that a person may wear a hole in the bottom of his or her foot much in the way that he or she may wear a hole in a stocking. Certainly, the early detection of a level of peripheral neuropathy sufficient to contribute to the development of foot wounds or "loss of protective sensation" is one of the most important criteria to identify high risk patients for foot complications and is paramount when instituting a structured treatment plan to prevent lower extremity complications. The objective of the study is to determine the efficacy of the application of a series of Anodyne in-home treatments over a 90-day period to improve peripheral sensation and self-reported quality of life in persons with diabetes mellitus. This pilot study should provide preliminary data to determine if additional clinical evaluation is warranted and to determine an appropriate sample size. The hypothesis is the Anodyne therapy will improve sensory function over the course of therapy compared to sham therapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Diabetic Neuropathy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Factorial Assignment
Masking
Double
Allocation
Randomized
Enrollment
60 (false)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Anodyne Therapy System
Primary Outcome Measure Information:
Title
changes in sensation using, vibration perception threshold testing, monofilament testing, and the Michigan Neuropathy Screening Instrument

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects with diabetes mellitus and peripheral sensory neuropathy. Subjects at least 25 years old. Vibration perception threshold (VPT) ≥ 20 volts and ≤ 45 volts. Subjects must be alert, oriented, mentally competent and able to understand and comply with the requirements of the study, and provide voluntary informed consent. Subjects must be willing and able to complete the required study visits and record treatment activity in the study logbook. Exclusion Criteria: Subjects who have a VPT <20 or > 45 volts. Subjects with uncontrolled hypertension greater than 180 systolic or greater than 110 diastolic as determined by enrollment questionnaire Subjects who are pregnant or breastfeeding or who are likely to become pregnant during the course of the study. Subjects with active malignancy (including basal cell carcinoma) on the lower extremities. Subjects who have had prior reconstructive or replacement knee surgery with neurological deficits related to the surgery. ( If the patient has had knee surgery, their neuropathy appears to be uniform and bilateral, then they can be included in the study). Subjects with a history of previous back surgery, spinal stenosis, or spinal compression or radiculopathy with neurological deficits related to spinal cord pathology. ( If the patient has had back surgery, their neuropathy appears to be uniform and bilateral, then they can be included in the study). Subjects who are non-ambulatory. Subjects with a history of neuromuscular disease, leprosy, chronic alcoholism, or sarcoidosis. Subjects with foot ulcerations. Subjects with a transmetatarsal amputation or higher
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lawrence A Lavery, DPM
Organizational Affiliation
Scott and White Memorial Hospital & Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Scott and White Santa Fe Center
City
Temple,
State/Province
Texas
ZIP/Postal Code
76504
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
17977931
Citation
Lavery LA, Murdoch DP, Williams J, Lavery DC. Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy. Diabetes Care. 2008 Feb;31(2):316-21. doi: 10.2337/dc07-1794. Epub 2007 Oct 31.
Results Reference
derived

Learn more about this trial

Anodyne Therapy in Diabetic Sensory Neuropathy

We'll reach out to this number within 24 hrs